Olezarsen now covers severe hypertriglyceridemia; plozasiran remains FCS-only. Neha Pagidipati, MD, on what the split means for practice.

Nearly a decade ago, a landmark trial of deep brain stimulation for depression failed to show efficacy. Now researchers are ...

Extreme spicy food challenges can cause gastrointestinal symptoms and, in rare cases, severe reactions, prompting health ...

An analysis using data from three long-running studies on the effect of lifestyle and health provides more support for ...

Propofol infusion may not offer better 30-day recovery or survival outcomes after major noncardiac surgery compared with ...

Hyponatraemia during the first 72 hours of life is linked to later neurodevelopmental disorders or death in infants with ...

Opioid use disorder is associated with a higher risk for complications before discharge after inpatient removal of the uterus ...

Ankle strength shows no clear association with foot posture or general joint hypermobility in children, with only weak links ...

When added to semaglutide or placebo, glucose-dependent insulinotropic polypeptide (GIP) shows no effect on glycemic control ...

About one1 in five5 patients with adrenal incidentalomas hadve changes in cortisol status over time, suggesting that routine ...

Excess fat deposition in the pancreas is linked to an increased risk for all-cause mortality, particularly from vascular ...

As varicella cases reemerge in some parts of the country, newly published guidance helps clinicians navigate an ‘old’ disease ...